I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Auranofin-Loaded Chitosan Nanoparticles Demonstrate Potency..:
Maame Abena O. Afrifa
;
Jong H. Kim
;
Kathryn A. Pitton
...
doi:10.1021/acsabm.4c00184.s001. , 1753
Link:
https://doi.org/10.1021/acsabm.4c00184.s001
RT Journal T1
Auranofin-Loaded Chitosan Nanoparticles Demonstrate Potency against Triple-Negative Breast Cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftgriffithunifig:oai:figshare.com:article_25355928&Exemplar=1&LAN=DE A1 Maame Abena O. Afrifa A1 Jong H. Kim A1 Kathryn A. Pitton A1 Chibuzor Olelewe A1 Adedamola S. Arojojoye A1 Douglas R. Strachan A1 Mark A. Suckow A1 Samuel G. Awuah YR 1753 K1 Biophysics K1 Biochemistry K1 Medicine K1 Pharmacology K1 Biotechnology K1 Space Science K1 Chemical Sciences not elsewhere classified K1 negative breast cancer K1 enhance anticancer activity K1 effective anticancer agents K1 derived compounds including K1 cp 2 np K1 unique cationic properties K1 good delivery carrier K1 excellent delivery system K1 altered physiochemical properties K1 clinical challenge due K1 overshadow chitosan ' K1 validated drug targets K1 vivo studies revealed K1 chitosan polymer surface K1 peg onto chitosan K1 >- peg nanoparticles K1 vivo studies K1 peg onto K1 >- peg K1 inherent properties K1 delivery paradigms K1 parent polymer K1 clinical limitations K1 chitosan -< K1 free drug K1 approved drug K1 shown promise K1 several tumors K1 process influenced K1 potentially reducing K1 neutral ph K1 mediated engraftment K1 genetic heterogeneity K1 g </ K1 full functionality K1 factor crucial K1 afm ) K1 5 mg K1 3 mg JF doi:10.1021/acsabm.4c00184.s001 LK http://dx.doi.org/https://doi.org/10.1021/acsabm.4c00184.s001 DO https://doi.org/10.1021/acsabm.4c00184.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)